Next 10 |
home / stock / karbf / karbf news
HUDDINGE, Sweden , July 21, 2020 /PRNewswire/ -- Q2, April - June Net sales amounted to MSEK 688.9 (387.4). This corresponds to an increase of 78% for the period. The organic growth during the second quarter was -10%, currency impact 0% and 88% relates to the acquisition of ...
HUDDINGE, Sweden , May 26, 2020 /PRNewswire/ -- At today's annual general meeting of Karo Pharma, the following decisions were passed. The annual general meeting resolved to adopt the income statement and balance sheet for the group and the parent company. The annual general meeting res...
HUDDINGE, Sweden , May 8, 2020 /PRNewswire/ -- Karo Pharma Aktiebolag ("Karo Pharma") today announces the signing and closing of the acquisition of the remaining European rights to the Pevaryl ® brand portfolio from Cilag GmbH International, one of the Janssen Pharmaceutical C...
HUDDINGE, Sweden , April 29, 2020 /PRNewswire/ -- January - March Net sales amounted to MSEK 793.6 (420.8). This corresponds to an increase of 89% for the period. The organic growth during the first quarter was 27%, currency impact -1% and 63% relates to the acquisition of Trimb in 201...
HUDDINGE, Sweden , April 1, 2020 /PRNewswire/ -- Today, on 1 April 2020 , Karo Pharma is publishing its annual report for 2019 on the company's website, www.karopharma.com . ABOUT KARO PHARMA Karo Pharma specialises in the sales and marketing of prescription drugs and over the cou...
HUDDINGE, Sweden , March 27, 2020 /PRNewswire/ -- The board of directors of Karo Pharma Aktiebolag ("Karo Pharma") has resolved to postpone the Annual General Meeting to 25 May, 2020 . The previously communicated date for the meeting was 29 April 2020 . The delay is due to the increased...
HUDDINGE, Sweden , Feb. 19, 2020 /PRNewswire/ -- OCTOBER - DECEMBER Net sales amounted to MSEK 649.3 (463.3). This corresponds to an increase of 40% for the period. The organic growth during the fourth quarter was -4 %, currency impact 2 % and 42 % refers to the acquisition of Trimb....
HUDDINGE, Sweden , Dec. 23, 2019 /PRNewswire/ -- Karo Pharma acquires a focused intimate care and dermatology product portfolio from the Danish pharmaceutical company LEO Pharma for 90 MEUR. The turnover of the acquired portfolio is estimated to 35 MEUR for the full year of 2019. Approx...
STOCKHOLM , Dec. 11, 2019 /PRNewswire/ -- Åsa Riisberg has notified the Board of Directors of Karo Pharma that she, due to a number of time-consuming commitments, wishes to leave her position as member of the Board of Directors. She resigned from the Board of Directors 10 December 2...
HUDDINGE, Sweden , Nov. 27, 2019 /PRNewswire/ -- As previously communicated, Karo Pharma Aktiebolag (" Karo Pharma ") voluntarily and within a certain time undertook to divest Hydrokortison Trimb and all intellectual property rights and assets relating thereto, including necessary license...
News, Short Squeeze, Breakout and More Instantly...
Karo Pharma Aktiebolag Company Name:
KARBF Stock Symbol:
OTCMKTS Market:
HUDDINGE, Sweden , July 21, 2020 /PRNewswire/ -- Q2, April - June Net sales amounted to MSEK 688.9 (387.4). This corresponds to an increase of 78% for the period. The organic growth during the second quarter was -10%, currency impact 0% and 88% relates to the acquisition of ...
HUDDINGE, Sweden , May 26, 2020 /PRNewswire/ -- At today's annual general meeting of Karo Pharma, the following decisions were passed. The annual general meeting resolved to adopt the income statement and balance sheet for the group and the parent company. The annual general meeting res...
HUDDINGE, Sweden , May 8, 2020 /PRNewswire/ -- Karo Pharma Aktiebolag ("Karo Pharma") today announces the signing and closing of the acquisition of the remaining European rights to the Pevaryl ® brand portfolio from Cilag GmbH International, one of the Janssen Pharmaceutical C...